Evaluating Safety and efficacy in retrospective ANAlysis after switching Drug to topiroxostat Among patients with hyperuricemia study
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Topiroxostat (Primary)
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- Acronyms SANADA
- 10 Feb 2018 Status changed from active, no longer recruiting to completed.
- 12 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Aug 2016 New trial record